Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Publication year range
1.
Cancers (Basel) ; 15(5)2023 Mar 02.
Article in English | MEDLINE | ID: mdl-36900346

ABSTRACT

During radiation therapy (RT) of glioblastoma, daily MRI with combination MRI-linear accelerator (MRI-Linac) systems has demonstrated significant anatomic changes, including evolving post-surgical cavity shrinkage. Cognitive function RT for brain tumors is correlated with radiation doses to healthy brain structures, especially the hippocampi. Therefore, this study investigates whether adaptive planning to the shrinking target could reduce normal brain RT dose with the goal of improving post-RT function. We evaluated 10 glioblastoma patients previously treated on a 0.35T MRI-Linac with a prescription of 60 Gy delivered in 30 fractions over six weeks without adaptation ("static plan") with concurrent temozolomide chemotherapy. Six weekly plans were created per patient. Reductions in the radiation dose to uninvolved hippocampi (maximum and mean) and brain (mean) were observed for weekly adaptive plans. The dose (Gy) to the hippocampi for static vs. weekly adaptive plans were, respectively: max 21 ± 13.7 vs. 15.2 ± 8.2 (p = 0.003) and mean 12.5 ± 6.7 vs. 8.4 ± 4.0 (p = 0.036). The mean brain dose was 20.6 ± 6.0 for static planning vs. 18.7 ± 6.8 for weekly adaptive planning (p = 0.005). Weekly adaptive re-planning has the potential to spare the brain and hippocampi from high-dose radiation, possibly reducing the neurocognitive side effects of RT for eligible patients.

2.
J Pediatr ; 149(3): 320-3, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16939740

ABSTRACT

OBJECTIVE: To determine whether coronary artery calcification (CAC), elevated fasting lipids, and lipoproteins and peripheral inflammatory markers are present in insulin-dependent diabetic adolescents and young adults several years after diagnosis. STUDY DESIGN: Hispanic insulin-dependent diabetics (n = 32) diagnosed a mean of 7.8 +/- 4.5 years ago (range, 3 to 16 years), with a mean glycosylated hemoglobin concentration at the time of the study of 8.8% +/- 2.3% and a mean chronological age of 16.1 +/- 4.4 years, were evaluated. Healthy patients (n = 15) with a chronological age (CA) of 15.2 +/- 2.2 years served as control subjects. CAC was assessed by multiple slice computed tomography, and total CAC score in Agatston units was calculated. Fasting lipids, C-reactive protein, apolipoprotein (Apo) A, Apo B, and metalloproteinase-9 (MMP-9) concentrations were measured in all subjects. RESULTS: Neither adolescents with type 1 diabetes nor healthy control subjects presented with evidence of CAC. Fasting lipids, Apo A, Apo B, CRP, and MMP-9 concentrations were similar between diabetic subjects and control subjects. However, 34.4% and 25.0% of our type 1 diabetic subjects had elevated total and LDL cholesterol levels (>200 and >130 mg/dL, respectively), whereas 15.6% and 28.1% had elevated triglyceride and Apo B concentrations (>150 mg/dL and >100 mg/dL, respectively). In addition, 28.1% and 34.4% presented with elevated CRP and MMP-9 levels (>2 mg/L and >80 ng/mL, respectively). Total, LDL and HDL cholesterol, triglycerides, Apo B, CRP, and MMP-9 concentrations correlated positively with duration of the disease and with glycosylated hemoglobin levels. CONCLUSIONS: Although the study adolescents with type 1 diabetes did not present any radiologic evidence of CAC at this stage of the disease, they remain a high-risk group for the development of microvascular and macrovascular artery disease, as risk factors such as elevated lipoproteins and proinflammatory markers are already present in a significant percentage of patients studied.


Subject(s)
Calcinosis/diagnostic imaging , Coronary Artery Disease/diagnostic imaging , Diabetes Mellitus, Type 1/blood , Diabetes Mellitus, Type 1/diagnostic imaging , Lipids/blood , Adolescent , Adult , Apolipoproteins B/blood , C-Reactive Protein/metabolism , Calcinosis/blood , Calcinosis/etiology , Case-Control Studies , Child , Coronary Artery Disease/blood , Coronary Artery Disease/etiology , Diabetes Mellitus, Type 1/complications , Female , Humans , Male , Matrix Metalloproteinase 9/blood , Radiography
3.
Cell Mol Neurobiol ; 22(5-6): 827-34, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12585700

ABSTRACT

1. In this study we investigated the effect of 7-nitroindazole (7-NI), a preferential inhibitor of neuronal nitric oxide synthase (nNOS), on kainic acid (KA) induced neurotoxicity in rats. Choline acetyltransferase activity (CAT), a cholinergic marker, and histological changes were employed to assess neurotoxicity. 2. In control rats, the local intrastriatal injection of 0.5 microg of KA reduced CAT from 22.9 +/- 2.2 to 14.7 +/- 2.0 nmol/h/mg tissue ((38 +/- 6)% reduction) (P < 0.001). Greater reductions in CAT were observed with 1 and 2 microg of KA ((70 +/- 6)% and (80 +/- 3)%, respectively). 7-NI aggravated KA-induced cholinergic and histological damage. KA reduced CAT by (68.2 +/- 4)% in 7-NI-treated rats, by (38 +/- 6)% in saline-treated controls, and by (41 +/- 4)% in peanut-oil- (7-NI-vehicle-) treated rats (P = 0.0047). 3. After KA, CAT activity averaged 14.3 +/- 2.0 in peanut-oil-treated rats and 7.9 +/- 1.0 nmol/h/mg tissue in 7-NI- (peanut-oil-) treated rats (P = 0.015). Similarly to changes in CAT, 7-NI treatment aggravated KA-induced histological changes indicative of neuronal damage (acute ischemic neuronal changes, disorganization of myelinated fibers bundle, and vacuolation changes of the neuropil). Treatment with 7-NI was not associated with increased mortality. 4. Our findings suggest that neuronal NO plays a neuroprotective action on excitotoxicity.


Subject(s)
Cholinergic Fibers/drug effects , Enzyme Inhibitors/toxicity , Indazoles/toxicity , Kainic Acid/toxicity , Neostriatum/drug effects , Neurons/drug effects , Neurotoxins/toxicity , Nitric Oxide/metabolism , Animals , Cell Death/drug effects , Cell Death/physiology , Choline O-Acetyltransferase/metabolism , Cholinergic Fibers/metabolism , Drug Synergism , Neostriatum/metabolism , Nerve Degeneration/chemically induced , Nerve Degeneration/metabolism , Nerve Degeneration/physiopathology , Neurons/metabolism , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide Synthase/metabolism , Rats , Rats, Sprague-Dawley , Up-Regulation/drug effects , Up-Regulation/physiology
4.
Cell Mol Neurobiol ; 22(5-6): 835-44, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12585701

ABSTRACT

1. The existence of functional interrelationships between dorsal and ventral regions of the rat striatum was investigated. Kainic acid (KA) was employed to induce neuronal lesions in the more dorsal striatum, the caudate-putamen (CP). Only one CP (one side) received KA. KA-induced neurotoxicity at the site of injection (CP) was evidenced by reductions in choline-acetyltransferase activity and in GABA levels, and by increases in the ratios metabolite/monoamine for dopamine (DA) and serotonin (5-HT). 2. In addition to the well-known local effects, direct stereotaxic injection of KA into the CP produced distant effects in the ipsilateral olfactory tubercle (OT). A dose-dependent increase in the levels of 3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), and 5-hydroxyindoleacetic acid (5-HIAA) and decreases in DA and 5-HT concentrations were observed in the OT ipsilateral to the CP injected with KA. With 1, 2, 3, and 4 microg of KA, the ratio DOPAC+HVA/DA in the OT was 30, 79, 140, and 173% higher, respectively, than control levels. With 2, 3, and 4 microg of KA, the levels of 5-HIAA were approximately 30, 60, and 120% higher than control values, and the changes in 5-HIAA were associated with significant reductions in 5-HT concentrations. 3. Our results suggest that the dorsal part of the striatum exerts important regulatory functions over the most ventral striatal region, the OT. Destruction of CP interneurons by KA leads to disinhibition of DA and 5-HT activities to the OT. The functional interactions between dorsal and ventral striatal regions may play a role in the integration of fundamental life-preserving, motivational, and goal-directed olfactory motor behaviors of rodents.


Subject(s)
Dopamine/metabolism , Interneurons/metabolism , Neostriatum/metabolism , Nerve Degeneration/metabolism , Neural Pathways/metabolism , Olfactory Pathways/metabolism , Serotonin/metabolism , 3,4-Dihydroxyphenylacetic Acid/metabolism , Animals , Behavior, Animal/physiology , Cell Death/drug effects , Cell Death/physiology , Dose-Response Relationship, Drug , Homovanillic Acid/metabolism , Hydroxyindoleacetic Acid/metabolism , Interneurons/drug effects , Interneurons/pathology , Kainic Acid/pharmacology , Neostriatum/drug effects , Neostriatum/physiopathology , Nerve Degeneration/chemically induced , Nerve Degeneration/physiopathology , Neural Inhibition/drug effects , Neural Inhibition/physiology , Neural Pathways/drug effects , Neural Pathways/physiopathology , Neurotoxins/pharmacology , Olfactory Pathways/physiopathology , Rats , Rats, Sprague-Dawley
5.
Rev. méd. Hosp. Gen. Méx ; 59(1): 15-8, ene.-mar. 1996. ilus
Article in Spanish | LILACS | ID: lil-181522

ABSTRACT

La enterocolitis neutropénica es una complicación que se observa principalmente en pacientes con leucemia tratados con inmunosupresores citotóxicos que posteriormente, debido a su estado de inmunodepresión, presentan infección por agentes oportunistas como bacterias, virus u hongos. En este estudio se encontró que el 4 por ciento de 325 casos de leucemia en material de autopsias del Hospital General de México, presentaron esta complicación. En todos los casos hubo afección extensa del colon e ileon; en dos casos la muerte se debió a perforación y peritonitis. Además se encontraron casos con afección en sitios extraintestinales como lengua, esófago, bronquio y cérvix, por lo que consideramos que esta complicación no es exclusiva de la región enterocólica y proponemos el término de ®lesión neutropénica sistémica¼ cuando exista afección fuera de este sitio en múltiples órganos


Subject(s)
Humans , Male , Female , Child, Preschool , Adolescent , Adult , Middle Aged , Autopsy , Vincristine/adverse effects , Enterocolitis, Pseudomembranous/etiology , Enterocolitis, Pseudomembranous/pathology , Leukemia, Myeloid, Acute/complications , Leukemia, Myeloid, Acute/pathology , Leukemia, Myeloid, Acute/drug therapy , Doxorubicin/adverse effects , Methotrexate/adverse effects , Cytarabine/adverse effects , Precursor Cell Lymphoblastic Leukemia-Lymphoma/complications , Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL